Kyongbo Bounce Play PossibleAccording to RSI, the market has oversold. Potential market could bounce. Potential hit 12000 won. If price can not hold 9300, price could fall to 6900 won.
p.s. risk management is the key.
210 KRW
2.97 B KRW
216.36 B KRW
19.82 M
About KYONGBO PHARMACEUTICAL CO., LTD.
Sector
CEO
Tae-Young Kim
Headquarters
Asan-si
Website
Founded
1987
ISIN
KR7214390007
FIGI
BBG008QGFS64
KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include general, antibiotic, and anticancer active pharmaceutical ingredients, inhalation anesthetics, cefaclor capsules, and cefaclor dried syrups. The company was founded on March 31, 1987 and is headquartered in Asan-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 214390 is 7,440 KRW — it has decreased by −2.75% in the past 24 hours. Watch KYONGBO PHARMACEUTICAL CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KYONGBO PHARMACEUTICAL CO., LTD. stocks are traded under the ticker 214390.
214390 reached its all-time high on Jun 29, 2015 with the price of 38,500 KRW, and its all-time low was 4,580 KRW and was reached on Mar 19, 2020. View more price dynamics on 214390 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
214390 stock is 7.39% volatile and has beta coefficient of 1.26. Track KYONGBO PHARMACEUTICAL CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is KYONGBO PHARMACEUTICAL CO., LTD. there?
Yes, you can track KYONGBO PHARMACEUTICAL CO., LTD. financials in yearly and quarterly reports right on TradingView.
214390 net income for the last quarter is 1.08 B KRW, while the quarter before that showed 156.52 M KRW of net income which accounts for 590.90% change. Track more KYONGBO PHARMACEUTICAL CO., LTD. financial stats to get the full picture.
KYONGBO PHARMACEUTICAL CO., LTD. dividend yield was 0.60% in 2023, and payout ratio reached 40.19%. The year before the numbers were 0.50% and 195.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 514.00 employees. See our rating of the largest employees — is KYONGBO PHARMACEUTICAL CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KYONGBO PHARMACEUTICAL CO., LTD. EBITDA is 22.61 B KRW, and current EBITDA margin is 7.97%. See more stats in KYONGBO PHARMACEUTICAL CO., LTD. financial statements.
Like other stocks, 214390 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KYONGBO PHARMACEUTICAL CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KYONGBO PHARMACEUTICAL CO., LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KYONGBO PHARMACEUTICAL CO., LTD. stock shows the sell signal. See more of KYONGBO PHARMACEUTICAL CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.